Differential susceptibity of transgenic mice lacking one or both apolipoprotein alleles to folate and vitamin E deprivation

被引:3
作者
Shea, TB [1 ]
Ortiz, D [1 ]
Rogers, E [1 ]
机构
[1] Univ Massachusetts, Ctr Cellular Neurobiol & Neurodegenerat Res, Dept Biol Sci, Lowell, MA 01854 USA
关键词
apolipoprotein E; folate; vitamin E; neurodegeneration; oxidative stress;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The E4 allele of apolipoprotein E (ApoE) is associated with neurodegeneration in part due to increased oxidative stress. Transgenic mice lacking ApoE (-/-) represent a model for the consequences of deficiencies in ApoE function. Dietary deficiency in folate and vitamin E has previously been shown to potentiate the impact of ApoE deficiency; ApoE-/- mice deprived of folate and vitamin E for 1 month demonstrated increased oxidative damage in brain tissue and impaired cognitive performance as compared to ApoE+/+ mice. Since individuals homozygous for E4 can demonstrate more increased risk for neurodegeneration and an earlier age of onset than individuals heterozygous for E4, we tested the impact of folate and vitamin E deprivation on ApoE+/- mice. Thiobarbituric acid-reactive substances in brain tissue of ApoE+/- were significantly increased compared to ApoE+/+ mice, but this increase was less than that observed in ApoE-/- mice. By contrast, livers of ApoE+/- and -/- mice displayed an identical increase over that of +/+ mice. ApoE-/- mice, but not +/- or +/+ mice, exhibited impaired cognitive performance in maze trials when deprived of folate and vitamin E. These findings support the notion that homozygous deficiency of ApoE function can be more severe than heterozygous deficiency. They further suggest that the impact of partial deficiency in ApoE function may present a latent risk that may manifest only when compounded by other factors such as dietary deficiency.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 43 条
[1]  
Berr C, 2002, J Nutr Health Aging, V6, P261
[2]   Risk of Alzheimer disease with the ε4 allele for apolipoprotein E in a population-based study of men aged 62-73 years [J].
Breitner, JCS ;
Jarvik, GP ;
Plassman, BL ;
Saunders, AM ;
Welsh, KA .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (01) :40-44
[3]  
Butterfield DA, 2002, NEUROBIOL AGING, V23, P655
[4]   Lipid peroxidation and protein oxidation in Alzheimer's disease brain:: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress [J].
Butterfield, DA ;
Lauderback, CM .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (11) :1050-1060
[5]   Preclinical memory decline in cognitively normal apolipoprotein E-ε4 homozygotes [J].
Caselli, RJ ;
Graff-Radford, NR ;
Reiman, EM ;
Weaver, A ;
Osborne, D ;
Lucas, J ;
Uecker, A ;
Thibodeau, SN .
NEUROLOGY, 1999, 53 (01) :201-207
[6]   Effect of folate deficiency and folate and B-12 excess on memory functioning in young chicks [J].
Crowe, SF ;
Ross, CK .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 56 (02) :189-197
[7]   Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease [J].
Finton, MJ ;
Lucas, JA ;
Rippeth, JD ;
Bohac, DL ;
Smith, GE ;
Ivnik, RJ ;
Petersen, RC ;
Graff-Radford, NR .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2003, 9 (05) :751-759
[8]   Oxidative stress in brain aging - Implications for therapeutics of neurodegenerative diseases [J].
Floyd, RA ;
Hensley, K .
NEUROBIOLOGY OF AGING, 2002, 23 (05) :795-807
[9]   APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD [J].
Geroldi, C ;
Pihlajamäki, M ;
Laakso, MP ;
DeCarli, C ;
Beltramello, A ;
Bianchetti, A ;
Soininen, H ;
Trabucchi, M ;
Frisoni, GB .
NEUROLOGY, 1999, 53 (08) :1825-1832
[10]   Incorporating biomarkers into clinical drug trials in Alzheimer's disease [J].
Growdon, John H. .
JOURNAL OF ALZHEIMERS DISEASE, 2001, 3 (03) :287-292